Lipase from Pseudomonas and strain
US5489530A · kind A · utility
9Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 1993 |
| Grant date | Feb 6, 1996 |
| Priority date | — |
| Expiry date | Dec 28, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/918
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.